Skip to main content
RDY logo
RDY
(NYSE)
Dr. Reddy's Laboratories Limited
$13.24-- (--)
Loading... - Market loading

Dr. Reddy's Laboratories (RDY) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Dr. Reddy's Laboratories Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions INR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Dr. Reddy's Laboratories Limited (RDY) - Annual data in billions INR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Current Assets
Cash and Cash Equivalents14.657.115.7814.850.200.032.232.6418.14
Short-Term Investments43.2574.3656.0229.510.270.3122.5318.330.00
Cash & Short-Term Investments57.9181.4761.8044.370.470.3424.7620.9718.14
Accounts Receivable109.7995.3472.4966.760.840.8246.6350.2045.74
Inventory71.0963.5548.6750.880.620.4633.5829.0928.53
Other Current Assets11.337.695.183.290.090.1016.3018.9715.65
Total Current Assets250.11248.05204.25181.862.031.72114.50109.65100.38
Non-Current Assets
Property, Plant & Equipment (Net)97.7676.8966.4662.170.780.6954.0957.8757.16
Long-Term Investments15.205.264.704.320.120.063.344.656.84
Goodwill11.814.254.254.420.060.053.903.953.75
Intangible Assets96.8036.9530.8527.250.490.3744.3744.6744.93
Other Non-Current Assets2.795.350.130.220.010.011.061.201.19
Total Non-Current Assets242.88139.47117.60110.971.601.35110.93115.96119.45
Total Assets492.99387.52321.85292.833.633.07225.43225.60219.82
Current Liabilities
Accounts Payable20.0521.5517.8615.970.170.1410.309.210.00
Short-Term Debt38.9014.0311.1927.080.330.2716.3825.6343.74
Current Portion of Long-Term Debt0.000.003.800.000.000.000.000.000.00
Accrued Liabilities43.8624.7821.8420.0631.810.000.000.000.00
Deferred Revenue1.981.441.982.580.030.031.350.980.82
Other Current Liabilities66.4356.693.742.500.590.5132.8433.3339.78
Total Current Liabilities130.3996.0485.8594.021.140.9659.7069.6985.00
Non-Current Liabilities
Long-Term Debt7.865.991.283.800.090.0222.0025.095.45
Deferred Tax Liabilities14.110.910.830.060.000.000.610.731.20
Other Non-Current Liabilities2.302.841.290.830.010.010.924.365.33
Total Non-Current Liabilities25.4310.935.028.290.120.0625.5329.4510.78
Total Liabilities155.82106.9790.86102.301.261.0285.2399.1495.78
Stockholders' Equity
Common Stock0.830.830.830.830.010.010.830.830.83
Retained Earnings315.79265.26215.59175.712.131.91128.65113.87108.22
Accumulated Other Comprehensive Income3.980.650.890.760.130.033.053.987.81
Treasury Stock2.260.991.271.600.000.000.000.000.00
Additional Paid-in Capital12.7813.8110.249.760.090.107.687.797.19
Minority Interest3.780.000.000.000.000.000.000.000.00
Shares Outstanding0.830.830.830.830.000.000.000.000.00
Total Stockholders' Equity333.39280.55230.99190.532.372.05140.20126.46124.04
Total Liabilities & Equity492.99387.52321.85292.833.633.07225.43225.60219.82

Frequently Asked Questions About Dr. Reddy's Laboratories Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is RDY's debt level?

Review Dr. Reddy's Laboratories's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.